Epidemiological, phylogenetic, and resistance heterogeneity among in a major US Deep South healthcare center

Emma Graffice,Derek B. Moates,Sixto M. Leal Jr.,Megan Amerson-Brown,Juan J. Calix

DOI: https://doi.org/10.1101/2024.03.22.24304710

2024-03-25

Abstract:( ) disease in the U.S. is commonly attributed to outbreaks of one or two monophyletic carbapenem resistance (CR) lineages that vary by region. However, there is limited knowledge regarding epidemiology and population structure in the U.S. Deep South, and few studies compare contemporary CR and carbapenem-susceptible (Cs) , despite prevalence of the latter. We performed a 12-year time series analysis of cases in a large hospital in Birmingham, AL, and 89 isolates from an ongoing surveillance project started in November 2021 were analyzed by whole genome sequencing and antibiotic susceptibility testing (AST). Cumulative CR rate among 2462 cases since 2011 was 19.4%, with increased rates during winter months resulting from seasonal changes in Cs incidence. Sequenced CR belonged to clonal complex (CC) 1, CC108, CC250, CC2, and CC499. Most CR CCs were comprised of isolates that clustered apart from U.S. counterparts in phylogenetic analysis, despite being identified in unrelated cases occurring ≥3 months apart. In contrast, 38/47 (81%) Cs isolates each belonged to a distinct CC. CR isolates displayed lineage-distinct AST features, including unique carbapenem resistance genetic determinants and presumptive heteroresistance behaviors unique to CC108 and CC499 isolates. This first comprehensive analysis of cases in the U.S. Deep South revealed epidemiological trends consistent with those in other regions and an unusually high degree of phylogenetic diversity among regional CR isolates. We also describe emergent U.S. CR lineages whose unconventional antimicrobial resistance features must be integrated into ongoing diagnostic, treatment, and surveillance efforts.

Infectious Diseases (except HIV/AIDS)